drugset / Trial / NCT03725579

Anesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine

NCT03725579

Phase 2/3 Unknown 66 enrolled Cairo University
RandomizedParallel-groupTriple-blindPrevention

Summary

The aim of this prospective randomized clinical trial was compare between 2% Mepivacaine and 4% Articaine for inferior alveolar nerve blocks in patients with symptomatic irreversible pulpitis in mandibular molars as regards to their anesthetic efficiency; during access cavity preparation and instrumentation.

Timeline

Start
2018-09-15
Primary completion
2018-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Articaine Other / unclassified 3.4 ml Other
Subject Articaine Other / unclassified 4 % Other
Subject Mepivacaine Other / unclassified 2 % Other
Subject Mepivacaine Other / unclassified 3.6 ml Other

Indications